August 28, 2020 - Thermo Fisher Scientific Inc. (Boston, MA) announced that it has officially cut the ribbon on its new $40 million facility in Lenexa, Kansas, dedicated to viral transport media (VTM) production. The company also announced that the site will continue to expand to meet expected sustained demand for COVID-19 testing. Thermo Fisher says the facility has … [Read more...]
New studies investigate accuracy of noninvasive, continuous hemoglobin monitoring with Masimo SpHb on neonates
August 20, 2020 - Masimo announced that, in a study recently published in the Journal of Tropical Pediatrics, researchers evaluating Masimo SpHb (noninvasive, continuous hemoglobin monitoring) on neonatal patients concluded that the technology “offers reliable Hb [hemoglobin] values, which are comparable with the more traditional tHb [invasive venous blood … [Read more...]
Abbott releases new research on challenges of caring for cardiovascular patients
August 19, 2020 - New global research released by Abbott (Abbott Park, IL) takes a deep dive into the barriers of cardiovascular patient care and shows that more than 80% of physicians and hospital administrators view technology and data as critical to addressing challenges before, during, and after treatment. The goal of the survey was to uncover how data and technology … [Read more...]
Medtronic to acquire Companion Medical, a smart insulin pen company
August 11, 2020 - Medtronic plc (Dublin, Ireland) announced the planned acquisition of privately-held Companion Medical, manufacturer of InPen — the only U.S. FDA-cleared smart insulin pen system paired with an integrated diabetes management app. According to Medtronic, the addition of Companion Medical’s InPen to the company’s portfolio expands Medtronic’s ability to … [Read more...]
Pfizer announces agreement with Gilead to manufacture remdesivir for treatment of COVID-19
August 07, 2020 - Pfizer Inc. (New York, NY) announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of the investigational treatment for COVID-19. Under the terms of the agreement, Pfizer will provide … [Read more...]
Health o meter Professional Scales announces Medical Device Marketing Authorization certification from the Saudi Food & Drug Authority
August 05, 2020 - Health o meter Professional Scales was recently granted Medical Device Marketing Authorization (MDMA) certification by the Saudi Food & Drug Authority (SFDA). The SFDA regulates medical devices that are sold in the Saudi healthcare market. This certification allows Health o meter Professional Scales to continue the expansion of their global reach … [Read more...]
Masimo: New study shows greater depth of patient sedation than intended during procedural colonoscopy
August 04, 2020 - Masimo (Irvine, CA) announced that, in a new study published in Anesthesia Research and Practice, researchers used Masimo SedLine Brain Function Monitoring to investigate the depth of anesthesia of patients receiving propofol for outpatient colonoscopy. The role of anesthesiologists in keeping patients appropriately sedated, and not over- or … [Read more...]
Abbott announces start of study to evaluate new device to treat recurrent AFib
August 04, 2020 - Abbott (Abbott Park, IL) announced first enrollments in the TactiFlex PAF IDE study to evaluate a new device to treat people suffering from paroxysmal atrial fibrillation (PAF), a type of irregular heartbeat. The study will evaluate the performance of the investigational TactiFlex Ablation Catheter, Sensor Enabled (SE) for people whose atrial … [Read more...]
Siemens Healthineers to acquire Varian Medical Systems for $16.4B
August 03, 2020 - Siemens Healthineers will acquire Varian Medical Systems (Palo Alto, CA) for about $16.4 billion in cash. Siemens offered $177.5 a share for Varian, 24% more than its closing price on Friday. The bid will be financed through both debt and equity, Siemens Healthineers says. The purchase will bring together two partners that have collaborated for more than … [Read more...]
Medtronic receives FDA approval for two new products: InterStim Micro Neurostimulator, InterStim SureScan MRI leads
August 03, 2020 - Medtronic plc (Dublin, Ireland) received approval from the U.S. Food and Drug Administration (FDA) for its InterStim Micro neurostimulator and InterStim SureScan MRI leads. InterStim Micro — the market’s smallest rechargeable device to deliver sacral neuromodulation (SNM) therapy — is used for treating overactive bladder (OAB), fecal incontinence (FI) and … [Read more...]